VANCOUVER, Feb. 2, 2017 /PRNewswire/ - Acuitas Therapeutics Inc., a private biotechnology company developing state-of-the-artlipid nanoparticle (LNP) delivery technology for messenger RNA (mRNA), announced today publication of data demonstrating that single low dose immunization with a messenger RNA delivered in an Acuitas LNP carrier has the potential to protect against infection
"I am delighted that our long-standing collaboration with Dr. Weissman continues to demonstrate the exciting clinical potential of mRNA therapeutics. The current data show that a single low dose administration of mRNA-LNP encoding a Zika protein completely protected animals from a subsequent challenge with the virus. We look forward to continuing our collaboration with Dr. Weissman to further advance this exciting new therapeutic modality," said Thomas Madden, Ph.D., President and Chief Executive Officer of Acuitas Therapeutics.
About messenger RNA (mRNA)Messenger RNA is a natural molecule that allows cells to produce proteins. Information that codes for a specific protein is contained on genes in the cell nucleus. This information is transcribed into a message (mRNA), which then migrates out of the nucleus and is translated into the specific protein. Synthetic mRNA can be introduced into a cell using Acuitas LNP carriers to direct the cell to produce a therapeutic protein. Such therapeutic proteins could replace a missing or defective protein, be an antibody to protect against infection, or provide a protective immune response (i.e. a vaccine).
About Acuitas TherapeuticsAcuitas Therapeutics is a private biotechnology company located in Vancouver, British Columbia, Canada developing novel LNP carriers for mRNA and other nucleic acid therapeutics, including technology developed under limited license from Arbutus Biopharma Corporation.
SOURCE Acuitas Therapeutics Inc
Subscribe to our Free Newsletters!
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...
Aniridia is a genetic eye disorder in which the iris is partially or entirely absent. It is ...
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...View All